These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 7637045

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Value of prostaglandin El in the diagnosis of erectile dysfunction in comparison with papaverine and papaverine/phentolamine in 61 patients with erectile dysfunction].
    Porst H.
    Urologe A; 1988 Jan; 27(1):22-6. PubMed ID: 3284144
    [Abstract] [Full Text] [Related]

  • 24. What nonresponse to intracavernous injection really indicates: a determination by quantitative analysis.
    Elhanbly S, Schoor R, Elmogy M, Ross L, Hegazy A, Niederberger C.
    J Urol; 2002 Jan; 167(1):192-6. PubMed ID: 11743303
    [Abstract] [Full Text] [Related]

  • 25. [Corpus cavernosum injection treatment of erectile impotence].
    Lenk S, Schönherr G, Korner I.
    Z Urol Nephrol; 1990 Oct; 83(10):539-46. PubMed ID: 2095661
    [Abstract] [Full Text] [Related]

  • 26. Double-blind, cross-over study comparing prostaglandin E1 and papaverine in patients with vasculogenic impotence.
    Kattan S, Collins JP, Mohr D.
    Urology; 1991 Jun; 37(6):516-8. PubMed ID: 2038782
    [Abstract] [Full Text] [Related]

  • 27. Prostaglandin E1 therapy for impotence, comparison with papaverine.
    Earle CM, Keogh EJ, Wisniewski ZS, Tulloch AG, Lord DJ, Watters GR, Glatthaar C.
    J Urol; 1990 Jan; 143(1):57-9. PubMed ID: 2294263
    [Abstract] [Full Text] [Related]

  • 28. Effect of multidose intracorporeal injection and audiovisual sexual stimulation in vasculogenic impotence.
    Katlowitz N, Albano GJ, Patsias G, Golimbu M, Morales P.
    Urology; 1993 Dec; 42(6):695-7. PubMed ID: 8256402
    [Abstract] [Full Text] [Related]

  • 29. The change of penile blood thromboxane B2 and prostacyclin after intracavernous injection of vasoactive drugs for the treatment of arteriogenic impotence.
    Lin JS, Chang WC, Lui SM.
    Proc Natl Sci Counc Repub China B; 1994 Jan; 18(1):12-6. PubMed ID: 8029369
    [Abstract] [Full Text] [Related]

  • 30. Experience with triple-drug therapy in a pharmacological erection program.
    Govier FE, McClure RD, Weissman RM, Gibbons RP, Pritchett TR, Kramer-Levien D.
    J Urol; 1993 Dec; 150(6):1822-4. PubMed ID: 8230514
    [Abstract] [Full Text] [Related]

  • 31. [Intracavernous pharmacotherapy for organic impotence in the elderly].
    Richter S, Shalev M, Nissenkorn I.
    Harefuah; 1990 Aug; 119(3-4):66-7. PubMed ID: 2227669
    [Abstract] [Full Text] [Related]

  • 32. [Evaluation of clinical usefulness of direct drug injections for increasing local circulation, into cavernous bodies of the penis for treatment of erection impotence in patients with diabetes mellitus].
    Dembe K, Jasik M, Piechna K.
    Pol Tyg Lek; 1990 Aug; 49(1-3):19-20. PubMed ID: 8008670
    [Abstract] [Full Text] [Related]

  • 33. Intracavernous injection of alprostadil for erectile dysfunction.
    Med Lett Drugs Ther; 1995 Sep 29; 37(958):83-4. PubMed ID: 7674992
    [No Abstract] [Full Text] [Related]

  • 34. Long-term intracavernous therapy responders can potentially switch to sildenafil citrate after radical prostatectomy.
    Raina R, Lakin MM, Agarwal A, Ausmundson S, Montague DK, Zippe CD.
    Urology; 2004 Mar 29; 63(3):532-7; discussion 538. PubMed ID: 15028452
    [Abstract] [Full Text] [Related]

  • 35. [Effectiveness and safety of cavernous body auto-injection therapy with papaverine/phentolamine. Study group].
    Thon WF, Hartmann U.
    Urologe A; 1993 Nov 29; 32(6):466-9. PubMed ID: 8284856
    [Abstract] [Full Text] [Related]

  • 36. [Response to intracavernous administration of 3 different drugs in the same group of patients with erectile dysfunction].
    Ribé N, Rajmil O, Bassas L, Jurado C, Pomerol JM.
    Arch Esp Urol; 2001 May 29; 54(4):355-9. PubMed ID: 11455770
    [Abstract] [Full Text] [Related]

  • 37. [Prostaglandin E1 injection in erectile dysfunction. Current diagnostic and therapeutic possibilities].
    Schrey A.
    Fortschr Med; 1990 Oct 20; 108(30):577-80. PubMed ID: 2245960
    [Abstract] [Full Text] [Related]

  • 38. [Efficacy of intracavernous injection of papaverine and prostaglandin in the diagnosis and treatment of erectile impotence].
    Martin-du Pan R.
    Rev Med Suisse Romande; 1989 Apr 20; 109(4):291-8. PubMed ID: 2660216
    [No Abstract] [Full Text] [Related]

  • 39. [Preliminary results of the treatment of erectile impotence by intracavernous self administration of vasoactive substances].
    Stief CG, Bähren W, Beckert R, Altwein JE.
    J Urol (Paris); 1986 Apr 20; 92(6):349-51. PubMed ID: 3794379
    [Abstract] [Full Text] [Related]

  • 40. A clinical comparative study on effects of intracavernous injection of sodium nitroprusside and papaverine/phentolamine in erectile dysfunction patients.
    Fu Q, Yao DH, Jiang YQ.
    Asian J Androl; 2000 Dec 20; 2(4):301-3. PubMed ID: 11202421
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.